Dr. Tauth studies various aspects of cardiovascular health, primarily focusing on treatments and interventions for heart conditions and arterial blockages. He investigates the effectiveness of specific drugs during heart procedures, such as how cangrelor can reduce complications during surgeries to open blocked arteries. Additionally, he examines rare heart issues like pseudoaneurysms and myocardial bridging, which can lead to heart attacks without traditional risk factors. His work is not only aimed at improving immediate treatment outcomes but also at better understanding the factors affecting heart health.
Key findings
In a study of the S.M.A.R.T. Vascular Stent System, 81.7% of patients maintained open arteries one year after treatment, with no major complications reported in the first 30 days.
Cangrelor reduced serious complications during heart procedures from 5.9% to 4.7%, without increasing severe bleeding risks (0.16% for cangrelor compared to 0.11% for clopidogrel).
In his study of coronary arterial remodeling patterns, 35% of patients experienced beneficial changes in artery shape, while 34% faced harmful changes, with smoking being a significant risk factor.
Dr. Tauth's case study on myocardial bridging showed that a patient had a heart attack without traditional blockages, allowing for effective treatment with medication instead of surgery.
His research on end-of-life medical interventions advocates for balanced decision-making to avoid unnecessary suffering, emphasizing the need for clear guidelines.
Frequently asked questions
Does Dr. Tauth study heart disease?
Yes, Dr. Tauth specializes in various heart conditions, including coronary artery issues and treatments for heart attacks.
What treatments has Dr. Tauth researched?
He has researched the effectiveness of stents, the use of the drug cangrelor during heart procedures, and management strategies for rare heart conditions.
Is Dr. Tauth's work relevant for patients with arterial blockages?
Absolutely, his research directly helps patients with blocked arteries in their legs and those undergoing heart procedures.
What is myocardial bridging and how does it relate to Dr. Tauth's research?
Myocardial bridging is a condition where heart muscle presses on a coronary artery, causing heart attacks. Dr. Tauth studied this to highlight that some heart attacks are not due to traditional plaque buildup.
How does Dr. Tauth's research impact end-of-life care?
His work on advanced medical interventions at the end of life emphasizes the importance of making thoughtful decisions to prevent unnecessary suffering.
Publications in plain English
S.M.A.R.T. self-expanding nitinol stent for the treatment of atherosclerotic lesions in the superficial femoral artery (STROLL): 1-year outcomes.
2015
Journal of vascular and interventional radiology : JVIR
Gray WA, Feiring A, Cioppi M, Hibbard R, Gray B +10 more
Plain English The study looked at the S.M.A.R.T. Vascular Stent System, which is used to treat blockages in the arteries of the leg. After one year, the stent showed strong effectiveness with 81.7% of patients maintaining open arteries, and no major complications were reported in the first 30 days. This is important because it demonstrates that the stent can improve blood flow and reduce severe symptoms related to artery blockages, making life easier for patients.
Who this helps: This helps patients with blocked arteries in their legs.
Effect of platelet inhibition with cangrelor during PCI on ischemic events.
2013
The New England journal of medicine
Bhatt DL, Stone GW, Mahaffey KW, Gibson CM, Steg PG +20 more
Plain English This study looked at the drug cangrelor compared to clopidogrel during heart procedures called percutaneous coronary interventions (PCI) in over 11,000 patients. It found that cangrelor reduced serious complications, like heart attacks or death, from 5.9% to 4.7% without increasing severe bleeding risks (0.16% for cangrelor vs. 0.11% for clopidogrel). This matters because using cangrelor can lead to better outcomes for patients undergoing PCI.
Who this helps: This helps patients undergoing heart procedures.
Pseudoaneurysm of the thoracic aorta presenting as purulent pericarditis and pericardial effusion.
1998
Catheterization and cardiovascular diagnosis
Aranda J, Tauth J, Henning RJ, O'Hara M
Plain English This study examined a patient with a rare condition where an infected bulge (pseudoaneurysm) formed in the thoracic aorta, leading to severe heart inflammation (purulent pericarditis). The patient had a 4 cm x 4 cm bulge detected in the aorta after draining fluid around the heart, which revealed the presence of a bacteria called Staphylococcus aureus. Despite needing surgery initially, the patient chose not to have the surgery and successfully treated the infection with antibiotics instead.
Who this helps: This research benefits doctors treating patients with similar heart conditions.
Myocardial infarction associated with myocardial bridging: case history and review of the literature.
1997
Catheterization and cardiovascular diagnosis
Tauth J, Sullebarger T
Plain English This study looked at a 38-year-old man who had a heart attack but didn't have blockages from traditional heart disease. Instead, his heart attack was caused by a condition called myocardial bridging, where heart muscle presses on a coronary artery. He recovered well with medication, highlighting that some heart attacks aren't due to plaque buildup and can be treated effectively.
Who this helps: This benefits patients with myocardial bridging who may face heart issues without typical risk factors.
Predictors of coronary arterial remodeling patterns in patients with myocardial ischemia.
1997
The American journal of cardiology
Tauth J, Pinnow E, Sullebarger JT, Basta L, Gursoy S +2 more
Plain English This study looked at 81 patients with heart problems and used ultrasound technology to examine their coronary arteries before a procedure to improve blood flow. They found that 35% of the patients experienced a beneficial change in their artery shape (adaptive remodeling), while 34% had a harmful change (constrictive remodeling). Smoking and certain types of plaque buildup in the arteries were linked to harmful changes, while smaller blood vessels and high cholesterol were linked to beneficial changes.
Who this helps: This research helps doctors understand patient conditions better and guide treatment for heart disease.
High technology near the end of life: setting limits.
1996
Journal of the American College of Cardiology
Basta L, Tauth J
Plain English This research paper looks at how advanced medical interventions at the end of life can sometimes do more harm than good, both for patients and for healthcare costs. The authors argue that instead of trying every possible treatment, which can lead to unnecessary suffering, doctors should create clear guidelines about when to use or avoid extreme measures like CPR. They stress the importance of involving both healthcare professionals and the public in making these decisions to ensure they reflect patients' best interests.
Who this helps: Patients and their families facing end-of-life decisions.